IE892931L - Use of ACE-inhibitors - Google Patents

Use of ACE-inhibitors

Info

Publication number
IE892931L
IE892931L IE892931A IE293189A IE892931L IE 892931 L IE892931 L IE 892931L IE 892931 A IE892931 A IE 892931A IE 293189 A IE293189 A IE 293189A IE 892931 L IE892931 L IE 892931L
Authority
IE
Ireland
Prior art keywords
vessel
prevention
ace
inhibitors
neointima
Prior art date
Application number
IE892931A
Original Assignee
James Andrew Marcelin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by James Andrew Marcelin filed Critical James Andrew Marcelin
Publication of IE892931L publication Critical patent/IE892931L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/005—Enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
  • Prostheses (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)

Abstract

ACE inhibitors are able to suppress the formation of neointima and the reduction of the vessel volume owing to vessel wall thickening after a vessel injury. They are accordingly suitable for the treatment and prevention of neointima formation after vessel injury, in particular for the prevention of arterial restenosis after angioplasty or of vessel wall thickening after vascular surgery in arteries and veins.
IE892931A 1988-09-14 1989-09-13 Use of ACE-inhibitors IE892931L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH342188 1988-09-14

Publications (1)

Publication Number Publication Date
IE892931L true IE892931L (en) 1990-03-14

Family

ID=4255625

Family Applications (1)

Application Number Title Priority Date Filing Date
IE892931A IE892931L (en) 1988-09-14 1989-09-13 Use of ACE-inhibitors

Country Status (13)

Country Link
EP (1) EP0363671B1 (en)
JP (1) JPH02121922A (en)
KR (1) KR900004337A (en)
AT (1) ATE100716T1 (en)
AU (1) AU625693B2 (en)
DE (1) DE58906814D1 (en)
DK (1) DK452089A (en)
ES (1) ES2061853T3 (en)
HU (1) HU206186B (en)
IE (1) IE892931L (en)
IL (1) IL91572A (en)
PT (1) PT91705B (en)
ZA (1) ZA896851B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3925759A1 (en) * 1989-08-03 1991-02-07 Thera Patent Verwaltungs Gmbh USE OF ACE INHIBITORS FOR ATHEROSKLEROSEPROPHYLAXE
DE3926606A1 (en) * 1989-08-11 1991-02-14 Hoechst Ag METHOD FOR THE TREATMENT OF CARDIALS AND VASCULAR HYPERTROPHY AND HYPERPLASIA
US5061694A (en) * 1989-10-23 1991-10-29 E. R. Squibb & Sons, Inc. Method for stabilizing or causing regression of atherosclerosis in coronary arteries employing an ace inhibitor
US5212165A (en) * 1989-10-23 1993-05-18 E. R. Squibb & Sons, Inc. Method for rehabilitating the vasorelaxant action of the coronary arteries impaired through atherosclerosis or hypercholesterolemia employing an ace inhibitor
US5140012A (en) * 1990-05-31 1992-08-18 E. R. Squibb & Sons, Inc. Method for preventing onset of restenosis after angioplasty employing pravastatin
CA2042159A1 (en) * 1990-05-31 1991-12-01 Miguel A. Ondetti Method for preventing onset of restenosis after angioplasty employing an ace inhibitor
CA2052014A1 (en) * 1990-10-19 1992-04-20 Henry Y. Pan Method for preventing diabetic complications employing a cholesterol lowering drug alone or in combination with an ace inhibitor
ATE157871T1 (en) 1994-05-19 1997-09-15 Mitsubishi Chem Corp MEDICINAL PRODUCTS FOR THE THERAPEUTIC AND PROPHYLACTIC TREATMENT OF DISEASES CAUSED BY HYPERPLASIA OF SMOOTH MUSCLE CELLS
JPH10508034A (en) * 1995-03-24 1998-08-04 モレキュメティックス リミテッド Beta-sheet mimics and their use as inhibitors of biologically active peptides or proteins
ATE243034T1 (en) * 1996-01-17 2003-07-15 Taiho Pharmaceutical Co Ltd INTIMAL THICKENING INHIBITORS
SI1216038T1 (en) * 1999-08-30 2006-02-28 Sanofi Aventis Deutschland Ramipril for the prevention of cardiovascular events
JP4904859B2 (en) * 2006-03-13 2012-03-28 大日本印刷株式会社 Printing unit and doctor blade polishing method
BRPI0621867A2 (en) * 2006-07-10 2011-12-20 Teva Pharma stable formulation consisting of a combination of a moisture sensitive drug and a second drug, and a process for its manufacture

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4105776A (en) 1976-06-21 1978-08-08 E. R. Squibb & Sons, Inc. Proline derivatives and related compounds
US4316906A (en) 1978-08-11 1982-02-23 E. R. Squibb & Sons, Inc. Mercaptoacyl derivatives of substituted prolines
AT377496B (en) 1981-06-19 1985-03-25 Voith Gmbh J M DEVICE FOR WINDING A TRACK OF GOODS ON A NEWLY INSERTED WRAPPING SLEEVE IN A DOUBLE-CARRIER ROLLING MACHINE

Also Published As

Publication number Publication date
HUT51148A (en) 1990-04-28
EP0363671A2 (en) 1990-04-18
ES2061853T3 (en) 1994-12-16
IL91572A (en) 1994-01-25
AU625693B2 (en) 1992-07-16
JPH02121922A (en) 1990-05-09
ZA896851B (en) 1990-06-27
AU4124089A (en) 1990-03-22
DK452089A (en) 1990-03-15
PT91705A (en) 1990-03-30
EP0363671B1 (en) 1994-01-26
IL91572A0 (en) 1990-04-29
PT91705B (en) 1995-05-31
KR900004337A (en) 1990-04-12
HU206186B (en) 1992-09-28
ATE100716T1 (en) 1994-02-15
DE58906814D1 (en) 1994-03-10
EP0363671A3 (en) 1991-12-11
DK452089D0 (en) 1989-09-13

Similar Documents

Publication Publication Date Title
IE892931L (en) Use of ACE-inhibitors
IE893123L (en) Use of gamma-interferon for the treatment of vascular¹stenosis
HUP9802093A3 (en) Use of nitrogen-monoxyde for producing medicament useful for treatment of vascular thrombosis and restenosis
ATE406909T1 (en) PREVENTION AND TREATMENT OF PATHOLOGIES ASSOCIATED WITH ABNORMAL PROLIFERATION OF SMOOTH MUSCLE CELLS
ATE186460T1 (en) METHOD FOR PREVENTING RESTENOSATION AFTER RECANALIZATION OF BODY VESSELS
NO861624L (en) PROTECTED ARTICLE.
NO992769D0 (en) Procedure for the treatment and prevention of heart failure and ventricular dilation
ATE253076T1 (en) ANTITHROMBOTIC DRUGS
AU6178094A (en) Polyurethane-coated intravascular prostheses (stents) for the treatment of blood vessel stenosis
AU5537994A (en) Therapeutic treatment for inhibiting vascular restenosis
WO2003032809A3 (en) Modulation of akt-dependent response to prevent restenosis
ATE216888T1 (en) DESFERRI-EXOCHELINE FOR THE TREATMENT OF ATHEROSCLERosis AND VASCULAR DAMAGE BY PREVENTING SMOOTH MUSCLE CELL PROLIFERATION
FI903936A7 (en) Treatment of hypertrophy and hyperplasia of the heart and blood vessels
EP0661981A1 (en) Use of hyaluronic acid and forms to prevent arterial restenosis.
UA37249C2 (en) Method for inhibiting stenosis and/or restenosis (variants), method for inhibiting restenosis upon surgery of coronary artery (variants), method for decreasing risk of non-acute ischemic complication upon reconstructive vascular surgery
NO924637L (en) PROCEDURE FOR PREVENTING REPEATING OF ARTERIES
EP0407229A3 (en) Laser catheter apparatus for use in arteries or other narrow paths within living organisms
Elbert et al. Endoluminal stent coatings consisting of adsorbing copolymers reduce neointimal hyperplasia in the pig
CS846287A1 (en) Aid for vascular prostheses treatment of venous origin
FR2669826B1 (en) CATHETER FOR DILATION OF THE ARTERIES.
IT228470Y1 (en) CATHETER FOR THE DESTRUCTION OF THE ARTERIES
GB9016609D0 (en) Compositions for the active or prophylactic treatment of intravascular coagulation or thrombosis
BG101472A (en) Vascular transplant and method for its preparation